H-CYTE, INC.
TAMPA, FL · Founded 2013 · CIK 0001591165 · Biotech · Public
Automated cell therapy manufacturing platform using microfluidic technology
hcyte.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $11M
- 6 Form D · May 2020
- 77 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20132014201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $4,000,000 | |
| Private capital raised | Form D · SEC | $1,398,033 | |
| Private capital raised | Form D · SEC | $340,000 | |
| Private capital raised | Form D · SEC | $6,000,000 | |
| Private capital raised | Form D · SEC | $2,880,195 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1583 | Versa Integrated Solutions, Inc. | — | — |
| 1584 | Stem Biotech LLC | — | $100M |
| 1585 | BeneFix, Inc. | — | $8.6M |
| 1586 | H-CYTE, INC. | — | $11M |
| 1587 | REGENERIX LLC | — | — |
| 1588 | CHEMILY, LLC | — | — |
| 1589 | REGENTIS BIOMATERIALS LTD. | — | $6.5M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- James AndrewsDirector
- Randal BetzDirector
- John BlankDirector
- Jesse CrowneDirector
- Jeremy DanielExecutive Officer
- Kevin EganExecutive Officer
- Charles FarraharExecutive Officer
- Jarrett GorlinDirector · Executive Officer
- Steve GorlinDirector
- Scott HaufeDirector
- C.A. HenniesDirector
- "Major General C.A. ""Lou""" HenniesDirector
- Thomas HillsDirector
- William HorneDirector · Executive Officer
- Patrick KullmanDirector · Executive Officer
- Patrick KullmannExecutive Officer
- Ron LawsonDirector
- Ann MillerExecutive Officer
- Jon MogfordDirector
- Raymond MonteleoneDirector
- Dennis MoonExecutive Officer
- Larry PapasanDirector
- Steve PeltsExecutive Officer
- John Thomas, Jr.Director
- Jeffery WrightExecutive Officer
- Jeffrey WrightExecutive Officer
- Michael YukowskyDirector
- Michael YurkowskyDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.